Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Fabio Perrotta, Vittorio Chino, Valentino Allocca, Vito D’Agnano, Chandra Bortolotto, Andrea Bianco, Angelo Guido Corsico & Giulia Maria Stella. (2022) Idiopathic pulmonary fibrosis and lung cancer: targeting the complexity of the pharmacological interconnection. Expert Review of Respiratory Medicine 16:10, pages 1043-1055.
Read now
Read now
Oznur Yilmaz, Fusun Oztay & Ozgecan Kayalar. (2015) Dasatinib attenuated bleomycin-induced pulmonary fibrosis in mice. Growth Factors 33:5-6, pages 366-375.
Read now
Read now
Ignacio Duran, Peter-Jürgen Goebell, Konstantinos Papazisis, Alain Ravaud, Thomas Weichhart, Jose Antonio Rodriguez-Portal & Klemens Budde. (2014) Drug-induced pneumonitis in cancer patients treated with mTOR inhibitors: management and insights into possible mechanisms. Expert Opinion on Drug Safety 13:3, pages 361-372.
Read now
Read now
Jeong Sup Song, Chun Mi Kang, Chan Kwon Park & Hyung Kyu Yoon. (2013) Thrombin induces epithelial-mesenchymal transition via PAR-1, PKC, and ERK1/2 pathways in A549 cells. Experimental Lung Research 39:8, pages 336-348.
Read now
Read now
Giorgos A Margaritopoulos, Katerina M Antoniou, Giannoula Soufla, Evi Vassalou, Demetrios A Spandidos & Nikos M Siafakas. (2011) Yin Yang-1(YY-1) expression in idiopathic pulmonary fibrosis. Journal of Receptors and Signal Transduction 31:2, pages 188-191.
Read now
Read now
Articles from other publishers (29)
Yang Miao, Yue Yang, Xiaohe Li, Lingxin Meng, Jiahe Mao, Jianwei Zhang, Jingjing Gao, Cheng Yang, Xiaoting Gu, Honggang Zhou & Yanping Zhang. (2023) Imrecoxib attenuates bleomycin-induced pulmonary fibrosis in mice. Heliyon 9:11, pages e20914.
Crossref
Crossref
Yuan Hou, Guoyu Wang, Shuo Han, Huaman Liu & Xinhua Jia. (2023) Network pharmacology and molecular docking to explore the pharmacological mechanism of Yifei Tongluo granules in treating idiopathic pulmonary fibrosis: A review. Medicine 102:22, pages e33729.
Crossref
Crossref
Pavel A. Solopov, Ruben Manuel Luciano Colunga Biancatelli, Christiana Dimitropolou, Tierney Day & John D. Catravas. (2022) Optimizing antidotal treatment with the oral HSP90 inhibitor TAS-116 against hydrochloric acid-induced pulmonary fibrosis in mice. Frontiers in Pharmacology 13.
Crossref
Crossref
Aijun Zhang, Yixuan Zou, Qingcui Xu, Shuo Tian, Jie Wang, Yilin Li, Renchao Dong, Liangzong Zhang, Juanjuan Jiang, Lili Wang, Kai Tao, Zhaoqing Meng & Yanqiu Liu. (2022) Investigation of the Pharmacological Effect and Mechanism of Jinbei Oral Liquid in the Treatment of Idiopathic Pulmonary Fibrosis Using Network Pharmacology and Experimental Validation. Frontiers in Pharmacology 13.
Crossref
Crossref
Yong Jiang, Yi-Zi Xie, Chen-Wen Peng, Kai-Nan Yao, Xue-Ying Lin, Shao-Feng Zhan, Hong-Fa Zhuang, Hui-Ting Huang, Xiao-Hong Liu, Xiu-Fang Huang & Hang Li. (2022) Modeling Kaempferol as a Potential Pharmacological Agent for COVID-19/PF Co-Occurrence Based on Bioinformatics and System Pharmacological Tools. Frontiers in Pharmacology 13.
Crossref
Crossref
Chuang Ma, Mingyue Lyu, Chilu Deng, Xia Liu, Yanmin Cui, Yixiao Shen, Xianjun Meng & Jin Zhao. (2022) Cyanidin-3-galactoside ameliorates silica-induced pulmonary fibrosis by inhibiting fibroblast differentiation via Nrf2/p38/Akt/NOX4. Journal of Functional Foods 92, pages 105034.
Crossref
Crossref
Lu Wang, Wenxiang Zhu, Rui Sun, Jing Liu, Qihong Ma, Binbin Zhang & Yuanyuan Shi. (2022) Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Wen-Yu-Jin against Pulmonary Fibrosis in a Mouse Model. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-16.
Crossref
Crossref
Jie He & Xiaoyan Li. (2022) Identification and Validation of Aging-Related Genes in Idiopathic Pulmonary Fibrosis. Frontiers in Genetics 13.
Crossref
Crossref
Ting Zhu, Zhifeng Ma, Haiyong Wang, Xiaoxiao Jia, Yuanlin Wu, Linhai Fu, Zhupeng Li, Chu Zhang & Guangmao Yu. (2020) YAP/TAZ affects the development of pulmonary fibrosis by regulating multiple signaling pathways. Molecular and Cellular Biochemistry 475:1-2, pages 137-149.
Crossref
Crossref
Evangelos Karatzas, Margarita Zachariou, Marilena M Bourdakou, George Minadakis, Anastasis Oulas, George Kolios, Alex Delis & George M Spyrou. (2020) PathWalks: identifying pathway communities using a disease-related map of integrated information. Bioinformatics 36:13, pages 4070-4079.
Crossref
Crossref
Margherita Sisto, Loredana Lorusso, Giuseppe Ingravallo, Domenico Ribatti & Sabrina Lisi. (2020) TGFβ1-Smad canonical and -Erk noncanonical pathways participate in interleukin-17-induced epithelial–mesenchymal transition in Sjögren's syndrome. Laboratory Investigation 100:6, pages 824-836.
Crossref
Crossref
David Bennett, Elena Bargagli, Nicola Bianchi, Claudia Landi, Antonella Fossi, Annalisa Fui, Piersante Sestini, Rosa Metella Refini & Paola Rottoli. (2020) Elevated level of Galectin-1 in bronchoalveolar lavage of patients with idiopathic pulmonary fibrosis. Respiratory Physiology & Neurobiology 273, pages 103323.
Crossref
Crossref
Hao Ruan, Ziwei Lv, Shuaishuai Liu, Liang Zhang, Kai Huang, Shaoyan Gao, Wenhua Gan, Xiaowei Liu, Shanshan Zhang, Kaiyue Helian, Xiaohe Li, Honggang Zhou & Cheng Yang. (2020) Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway. Journal of Pharmacy and Pharmacology 72:1, pages 44-55.
Crossref
Crossref
Dan Wang, Zhibin Yan, Lili Bu, Chunmei An, Bochuan Deng, Jianfeng Zhang, Jing Rao, Lu Cheng, Jingying Zhang, Bangzhi Zhang & Junqiu Xie. (2019) Protective effect of peptide DR8 on bleomycin-induced pulmonary fibrosis by regulating the TGF-β/MAPK signaling pathway and oxidative stress. Toxicology and Applied Pharmacology 382, pages 114703.
Crossref
Crossref
Jie Li, Qiaosheng Zhang, Zhuo Chen, Dechen Xu & Yadong Wang. (2019) A network-based pathway-extending approach using DNA methylation and gene expression data to identify altered pathways. Scientific Reports 9:1.
Crossref
Crossref
Sun-Wei Guo. (2018) Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis. Reproductive Medicine and Biology 17:4, pages 369-397.
Crossref
Crossref
Abolfazl Doostparast Torshizi & Linda Petzold. (2018) Sparse Pathway-Induced Dynamic Network Biomarker Discovery for Early Warning Signal Detection in Complex Diseases. IEEE/ACM Transactions on Computational Biology and Bioinformatics 15:3, pages 1028-1034.
Crossref
Crossref
Yanni Wang, Guojin Huang, Zhixia Wang, Huiping Qin, Biwen Mo & Changming Wang. (2018) Elongation factor-2 kinase acts downstream of p38 MAPK to regulate proliferation, apoptosis and autophagy in human lung fibroblasts. Experimental Cell Research 363:2, pages 291-298.
Crossref
Crossref
E. Karatzas, M. M. Bourdakou, G. Kolios & G. M. Spyrou. (2017) Drug repurposing in idiopathic pulmonary fibrosis filtered by a bioinformatics-derived composite score. Scientific Reports 7:1.
Crossref
Crossref
Ting Wang, Yuan Liu, Jing-Feng Zou & Zhen-Shun Cheng. (2017) Interleukin-17 induces human alveolar epithelial to mesenchymal cell transition via the TGF-β1 mediated Smad2/3 and ERK1/2 activation. PLOS ONE 12:9, pages e0183972.
Crossref
Crossref
Maria Alessandra Ragusa & Giulia Russo. (2016) ODEs approaches in modeling fibrosis. Physics of Life Reviews 17, pages 112-113.
Crossref
Crossref
Satish K. MadalaGeorge Thomas, Ramakrishna EdukullaCynthia DavidsonStephanie SchmidtAngelica Schehr & William D. Hardie. (2016) p70 ribosomal S6 kinase regulates subpleural fibrosis following transforming growth factor-α expression in the lung. American Journal of Physiology-Lung Cellular and Molecular Physiology 310:2, pages L175-L186.
Crossref
Crossref
BreAnne MacKenzie, Martina Korfei, Ingrid Henneke, Zaneta Sibinska, Xia Tian, Stefanie Hezel, Salma Dilai, Roxana Wasnick, Beate Schneider, Jochen Wilhelm, Elie El Agha, Walter Klepetko, Werner Seeger, Ralph Schermuly, Andreas Günther & Saverio Bellusci. (2015) Increased FGF1-FGFRc expression in idiopathic pulmonary fibrosis. Respiratory Research 16:1.
Crossref
Crossref
Zheng Yan, Zhang kui & Zhu Ping. (2014) Reviews and prospectives of signaling pathway analysis in idiopathic pulmonary fibrosis. Autoimmunity Reviews 13:10, pages 1020-1025.
Crossref
Crossref
Satish K. MadalaThomas R. KorfhagenStephanie SchmidtCynthia DavidsonRamakrishna EdukullaMachiko IkegamiShelia M. Violette, Paul H. Weinreb, Dean Sheppard & William D. Hardie. (2014)
Inhibition of the α
v
β
6
integrin leads to limited alteration of TGF-α-induced pulmonary fibrosis
. American Journal of Physiology-Lung Cellular and Molecular Physiology 306:8, pages L726-L735.
Crossref
Crossref
Bo Zhu, Ai-Qun Ma, Lan Yang & Xiao-Min Dang. (2013) Atorvastatin Attenuates Bleomycin-Induced Pulmonary Fibrosis via Suppressing iNOS Expression and the CTGF (CCN2)/ERK Signaling Pathway. International Journal of Molecular Sciences 14:12, pages 24476-24491.
Crossref
Crossref
K.M. ANTONIOU, K.D. SAMARA, I. LASITHIOTAKI, G.A. MARGARITOPOULOS, G. SOUFLA, I. LAMBIRI, I. GIANNARAKIS, I. DROSITIS, D.A. SPANDIDOS & N.M. SIAFAKAS. (2013) Differential telomerase expression in idiopathic pulmonary fibrosis and non-small cell lung cancer. Oncology Reports 30:6, pages 2617-2624.
Crossref
Crossref
HAI GUO, FUZHI JI, BAORUI LIU, XIAOFEI CHEN, JINGDONG HE, XIAOFENG ZHAO & JIENING GONG. (2013) Peiminine ameliorates bleomycin-induced acute lung injury in rats. Molecular Medicine Reports 7:4, pages 1103-1110.
Crossref
Crossref
Satish K. Madala, Stephanie Schmidt, Cynthia Davidson, Machiko Ikegami, Susan Wert & William D. Hardie. (2012) MEK-ERK Pathway Modulation Ameliorates Pulmonary Fibrosis Associated with Epidermal Growth Factor Receptor Activation. American Journal of Respiratory Cell and Molecular Biology 46:3, pages 380-388.
Crossref
Crossref